2019 International Congress

Tuesday, September 24, 2019

1:45pm-3:15pm

The relationship between constipation and alteration of gut microbiota in patients with Parkinson’s disease

BI. Zao An, M. Ye (Nanjing, China)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The role of Dopamine in Preparatory Inhibition: What can we learn from Parkinson’s disease?

E. Wilhelm, C. Quoilin, G. Derosiere, A. Jeanjean, J. Duqué (Brussels, Belgium)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The role of mitochondria in modifying penetrance of Parkin gene variants

M. Castelo, J. Trinh, A. Zanon, J. Rainer, P. Bauer, K. Kandaswamy, M. Werber, A. Rolfs, A. Grunewald, M. Borsche, K. Lohmann, C. Klein, P. Pramstaller, I. Pichler, A. Hicks (Bolzano, Italy)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The role of Parkinson’s disease-associated RHOT1/Miro1 variants in mitochondrial dysfunction and impaired cellular quality control

A. Chemla, C. Berenguer-Escuder, F. Massart, P. Seibler, C. Klein, D. Grossmann, A. Grünewald, R. Krüger (Belvaux, Luxembourg)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease

I. Miliukhina, E. Ermolenko, E. Gracheva, A. Istomina, M. Kotyleva, E. Agapova, A. Suvorov (Saint-Petersburg, Russian Federation)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The STN Sweet Spot for Tremor Control in Parkinson’s Disease

T. Stiep, A. Diaz, I. Cajigas, J. Jagid, C. Luca (Miami, FL, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The study on brain function network of Parkinson’s disease with depression

Y. Qiu, L. Wang (Guangzhou, China)

Classification of Movement Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

The SUNRISE-PD Study, a clinical trial of AXO-LENTI-PD: a CNS-directed gene therapy for the treatment of Parkinson’s Disease

G. Corcoran, P. Korner, J. Wright, Y. Mo, J. Benoit, K. Binley, J. Miskin, N. Tuckwell, D. Zamoryakhin, T. Foltynie, R. Barker, K. Mitrophanous, S. Palfi (New York, NY, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The trace of substantia nigra hyperechogenicity: a clinical observation

A. Alonso-Canovas, JL. Sendon-Moreno, G. Garcia-Ribas, N. Monterde-Gonzalez, C. Jara-Laguna, JC. Martinez-Castrillo, J. Masjuan (Madrid, Spain)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

The ultrasonographic assessment of vagus nerve atrophy comparison with autonomic dysfunction in Parkinson’s disease

T. Hirato, S. Abe, H. Saiki (Kita-Ku, Osaka, Japan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3